FORTUNA, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 474
AS - Asia 179
EU - Europa 159
AF - Africa 31
OC - Oceania 6
SA - Sud America 2
Totale 851
Nazione #
US - Stati Uniti d'America 459
SG - Singapore 96
CN - Cina 63
IT - Italia 51
SE - Svezia 28
CI - Costa d'Avorio 24
IE - Irlanda 24
FI - Finlandia 14
UA - Ucraina 10
DE - Germania 9
MX - Messico 9
NL - Olanda 8
IR - Iran 7
CA - Canada 6
AU - Australia 5
GB - Regno Unito 4
RO - Romania 4
NG - Nigeria 3
TR - Turchia 3
ZA - Sudafrica 3
BD - Bangladesh 2
BG - Bulgaria 2
IN - India 2
PE - Perù 2
PH - Filippine 2
SI - Slovenia 2
BE - Belgio 1
ES - Italia 1
FR - Francia 1
GH - Ghana 1
JP - Giappone 1
KZ - Kazakistan 1
MY - Malesia 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
Totale 851
Città #
Chandler 122
Singapore 84
Santa Clara 33
Napoli 24
Beijing 23
Millbury 18
Princeton 16
Boston 15
Des Moines 13
Wilmington 13
Jacksonville 12
Nanjing 10
Amsterdam 8
Lawrence 7
Ottawa 6
Redwood City 6
Shenyang 5
Changsha 4
Kronberg 4
Naples 4
Hangzhou 3
Iztapalapa 3
Johannesburg 3
Lagos 3
Tehran 3
Atlanta 2
Benito Juarez 2
Boardman 2
Dhaka 2
Duncan 2
Grosuplje 2
Hebei 2
Jiaxing 2
Lima 2
Makati City 2
Melbourne 2
Melegnano 2
Nanchang 2
New York 2
Philadelphia 2
Rome 2
Salerno 2
Seattle 2
Sibiu 2
Sofia 2
Tianjin 2
Almaty 1
Auckland 1
Brisbane 1
Brussels 1
Domicella 1
Falls Church 1
Florence 1
Frankfurt am Main 1
Garza García 1
Glasgow 1
Houston 1
Indiana 1
Istanbul 1
Kuching 1
Lanzhou 1
Lappeenranta 1
Madrid 1
Mexico 1
Milan 1
Mountain View 1
Orange 1
Padula 1
Reston 1
Shenzhen 1
Shijiazhuang 1
Taipei 1
Tappahannock 1
Tokyo 1
Urmia 1
Woodbridge 1
Totale 514
Nome #
Role of dystrophic epidermolysis bullosa in anxiety, depression, and self-esteem: a controlled cross-sectional study 63
Oral Health-related Quality of Life in Patients with Dystrophic Epidermolysis Bullosa 56
Metastatic prostate cancer presenting as paraneoplastic pemphigus: a favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy 55
Capecitabine-induced stomatitis: a likely pathogenetic mechanism of oral lichenoid mucositis 48
Delayed immunologic evidence in pemphigus vulgaris 44
Secondary syphilis mimicking pemphigus vulgaris 41
Management of reticular oral lichen planus patients with burning mouth syndrome-like oral symptoms: a pilot study 41
Escalating dose of adalimumab as monotherapy to treat unusual giant and refractory oral-pharyngeal ulcerations in Crohn's disease 40
Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review 38
Pain in Patients with Dystrophic Epidermolysis Bullosa: Association with Anxiety and Depression 37
oral pemphigus 36
Autoimmune Muco-Cutaneous Blistering Diseases in the South of Italy: A 25-Year Retrospective Study on 169 Patients 35
Global research trends in complex oral sensitivity disorder: A systematic bibliometric analysis of the framework 33
The usefulness of YouTube™ videos as a source of information on burning mouth syndrome 32
Gastric diffuse large B-cell lymphoma (DLBCL) exhibiting oral acanthosis nigricans and tripe palms 31
Sunitinib adverse event: oral bullous and lichenoid mucositis 31
Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology 30
Clinical features of gingival lesions in patients with dystrophic epidermolysis bullosa: a cross-sectional study 30
Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases 29
Genotype–oropharyngeal phenotype correlation in Mexican patients with dystrophic epidermolysis bullosa 29
Sleep quality and disturbances in patients with dystrophic epidermolysis bullosa 28
Global research trends in complex oral sensitivity disorder: A systematic bibliometric analysis of the structures of knowledge 28
The use of rituximab as an adjuvant in the treatment of oral pemphigus vulgaris 23
COVID-19 impact on post-traumatic stress symptoms in burning mouth syndrome: A multicentric study 11
Impact of medications on salivary flow rate in patients with xerostomia: a retrospective study by the Xeromeds Consortium 10
Totale 879
Categoria #
all - tutte 3.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 0 2 0 1 8 21 4
2020/202163 2 4 13 2 5 12 3 3 5 4 6 4
2021/2022155 4 3 0 0 1 3 3 2 30 2 52 55
2022/2023227 24 26 16 15 32 30 2 20 34 9 17 2
2023/2024109 14 17 8 0 4 0 2 29 1 6 22 6
2024/2025154 38 58 6 14 20 18 0 0 0 0 0 0
Totale 879